Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Julian Iturbe"'
Publikováno v:
Oncology Reviews, Vol 5, Iss 3 (2011)
Neoadjuvant therapy has four goals in breast cancer: decrease tumor volume to operate tumors that initially were inoperable, increase the number of conservative surgeries, evaluate the chemosensitivity in vivo and analyze the management of micrometas
Externí odkaz:
https://doaj.org/article/424979f09df54157bd108ede09dd0bf7
Autor:
Jose Pablo Leone, Carlos Teodoro Vallejo, Ariel Osvaldo Zwenger, Julieta Leone, Bernardo Amadeo Leone, Julian Iturbe
Publikováno v:
European Journal of Cancer. 71:7-14
Background Male breast cancer (MaBC) is an understudied disease; information about locoregional treatment and outcomes in patients with early stage is unknown. We aimed to analyse patient characteristics, locoregional treatment and overall survival (
Autor:
Julian Iturbe, Carlos Teodoro Vallejo, Bernardo Amadeo Leone, Jose Pablo Leone, G. Grosman, Maria C. Mac Donnell, J E Perez, Julieta Leone, Maria Ester Dominguez, Ariel Osvaldo Zwenger
Publikováno v:
The International Journal of Biological Markers. 31:300-308
Background Several mechanisms are involved in the development of resistance to therapy in locally advanced cervical squamous cell carcinoma (LACSCC). Studies have shown that CD44 and Lewis Y antigen (LeY) form a complex that is associated with chemor
Autor:
Julian Iturbe, Carlos Teodoro Vallejo, Bernardo Amadeo Leone, Ariel Osvaldo Zwenger, José Pablo Leone, Julieta Leone
Publikováno v:
Breast Cancer Research and Treatment. 152:601-609
Substantial controversy exists about the prognostic role of tumor subtypes in male breast cancer (MaBC). The aim of this study was to analyze the characteristics of each tumor subtype in MaBC and its association with prognosis compared with other fac
Autor:
Ariel Osvaldo Zwenger, Bernardo Amadeo Leone, Julian Iturbe, Carlos Teodoro Vallejo, Julieta Leone, Jose Pablo Leone
Background The presence of brain metastases at the time of initial breast cancer diagnosis (BMIBCD) is uncommon. Hence, the prognostic assessment and management of these patients is very challenging. The aim of this study was to analyse the influence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0840c0c6c6515f72b64b4fff180bf8ac
https://www.sciencedirect.com/science/article/pii/S0959804917300199
https://www.sciencedirect.com/science/article/pii/S0959804917300199
Autor:
Maria Ester Dominguez, Ariel Osvaldo Zwenger, Jose Pablo Leone, Julian Iturbe, A Romero, Julieta Leone, E. H. Ortiz, Hebe Margot Fasce, M Machiavelli, Mario Langui, Luis A. Romero Acuña, J E Perez, Carlos Teodoro Vallejo, Bernardo Amadeo Leone
Publikováno v:
Breast Cancer Research and Treatment. 143:313-323
Neoadjuvant chemotherapy (NAC) allows direct evaluation of the tumor's sensitivity to therapy, eradication of micrometastatic disease and the possibility of performing breast conserving surgery. The aim of this study was to describe long-term results
Autor:
Julian Iturbe, Jose Pablo Leone, Ariel Osvaldo Zwenger, Julieta Leone, Bernardo Amadeo Leone, Rohit Bhargava, Carlos Teodoro Vallejo
Publikováno v:
Breast cancer research and treatment. 156(3)
Prognostic factors in male breast cancer (MaBC) are controversial. The objective of this study was to analyze patient characteristics and prognostic factors in MaBC over the last decade. Using the Surveillance, Epidemiology, and End Results program,
Autor:
Bernardo Amadeo Leone, Carlos Teodoro Vallejo, Julian Iturbe, José Pablo Leone, Ariel Osvaldo Zwenger
Publikováno v:
Oncology Reviews, Vol 5, Iss 3 (2011)
Neoadjuvant therapy has four goals in breast cancer: decrease tumor volume to operate tumors that initially were inoperable, increase the number of conservative surgeries, evaluate the chemosensitivity in vivo and analyze the management of micrometas
Autor:
Palmira Perez Verdera, Carlos Teodoro Vallejo, J E Perez, Jose Pablo Leone, G. Grosman, Julieta Leone, Bernardo Amadeo Leone, Ariel Osvaldo Zwenger, Julian Iturbe
Publikováno v:
The International journal of biological markers. 30(3)
Background Several studies in solid tumors have shown that expression of excision repair cross-complementation group 1 (ERCC1) and class III β-tubulin (TUBB3) can predict response to chemoradiotherapy and might be prognostic factors. We assessed the
Autor:
Julian Iturbe, Julieta Leone, Ariel Osvaldo Zwenger, Carlos Teodoro Vallejo, Bernardo Amadeo Leone, Jose Pablo Leone
Publikováno v:
Journal of Clinical Oncology. 34:1056-1056
1056Background: Male breast cancer (MaBC) is an understudied disease, information about LRT and outcomes in patients (pts) with T1a,b,cN0M0 tumors is unknown. The aim of this study was to analyze p...